vTv Therapeutics Inc.
VTVT
$35.08
-$1.74-4.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.84M | -- | 17.00K | 17.00K | 17.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.84M | -- | 17.00K | 17.00K | 17.00K |
| Cost of Revenue | 24.01M | 17.86M | 16.19M | 12.39M | 11.73M |
| Gross Profit | 12.83M | -17.86M | -16.17M | -12.37M | -11.71M |
| SG&A Expenses | 15.87M | 14.95M | 13.65M | 13.25M | 13.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.88M | 32.81M | 29.83M | 25.64M | 25.07M |
| Operating Income | -3.04M | -32.81M | -29.82M | -25.62M | -25.06M |
| Income Before Tax | -729.00K | -31.08M | -28.38M | -23.87M | -22.90M |
| Income Tax Expenses | -- | -- | 0.00 | 0.00 | 0.00 |
| Earnings from Continuing Operations | -0.73 | -31.08 | -28.38 | -23.87 | -22.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.98M | 4.11M | 4.91M | 4.32M | 4.21M |
| Net Income | 2.25M | -26.97M | -23.47M | -19.56M | -18.69M |
| EBIT | -3.04M | -32.81M | -29.82M | -25.62M | -25.06M |
| EBITDA | -3.03M | -32.79M | -29.78M | -25.57M | -24.98M |
| EPS Basic | -0.63 | -3.35 | -3.32 | -3.12 | -3.01 |
| Normalized Basic EPS | -0.24 | -1.87 | -1.81 | -1.69 | -1.63 |
| EPS Diluted | -0.92 | -3.35 | -3.32 | -3.12 | -3.01 |
| Normalized Diluted EPS | -0.42 | -1.87 | -1.81 | -1.69 | -1.63 |
| Average Basic Shares Outstanding | 39.46M | 33.63M | 27.81M | 25.21M | 25.03M |
| Average Diluted Shares Outstanding | 41.69M | 33.63M | 27.81M | 25.21M | 25.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |